Nature

Nature, first published on 4 November 1869, is ranked the world s most cited interdisciplinary scientific journal by the Science Edition of the 2010 Journal Citation Reports. Most scientific journals are now highly specialized, and Nature is among the few journals (the other weekly journals Science and Proceedings of the National Academy of Sciences are also prominent examples) that still publish original research articles across a wide range of scientific fields. There are many fields of scientific research in which important new advances and original research are published as either articles or letters in Nature. Research scientists are the primary audience for the journal, but summaries and accompanying articles are intended to make many of the most important papers understandable to scientists in other fields and the educated general public. Towards the front of each issue are editorials, news and feature articles on issues of general interest to scientists, including current affairs, science funding, business, scientific ethics and research breakthroughs. There are also sections on books and arts. The remainder of the journal consists mostly of research articles, which are

Publisher
Nature Publishing Group
Country
United Kingdom
History
1869–present
Impact factor
36.101 (2010)
Some content from Wikipedia, licensed under CC BY-SA

Big data key to precision medicine's success

Technological advances are enabling scientists to sequence the genomes of cancer tumors, revealing a detailed portrait of genetic mutations that drive these diseases. But genomic studies are only one piece ...

Apr 15, 2015
popularity 77 comments 0

Biologists identify brain tumor weakness

Biologists at MIT and the Whitehead Institute for Biomedical Research have discovered a vulnerability of brain cancer cells that could be exploited to develop more-effective drugs against brain tumors.

Apr 08, 2015
popularity 67 comments 0

To beat leukemia, boost cell signaling, study suggests

A new study of acute lymphoblastic leukemia (ALL) led by UC San Francisco researchers puts an intriguing new twist on anti-cancer strategies. Rather than inhibiting cellular signals that arise from a cancer-driving ...

Mar 26, 2015
popularity 28 comments 0